21339-74-2

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 4-AMINO-2,5-DIMETHYLBENZOATE is used as an intermediate in the synthesis of various pharmaceuticals for its contribution to the development of analgesics and anti-inflammatory drugs. Its role in the creation of these medications is crucial, as it aids in the management of pain and inflammation.
Used in Organic Synthesis:
In the realm of organic synthesis, METHYL 4-AMINO-2,5-DIMETHYLBENZOATE is utilized as a building block for the synthesis of other organic compounds. Its structural properties make it a valuable component in creating a diverse range of chemical products.
Used in Dyes and Pigments Manufacturing:
METHYL 4-AMINO-2,5-DIMETHYLBENZOATE is also used in the manufacturing of dyes and pigments, where its chemical properties contribute to the coloration and stability of these products in various applications.

InChI:InChI=1/C10H13NO2/c1-6-5-9(11)7(2)4-8(6)10(12)13-3/h4-5H,11H2,1-3H3

Upstream product

• 953393-97-0 methyl 2,5-dimethyl-4-nitrobenzoate 
• 6933-47-7 methyl 4-amino-2-methylbenzoate 
• 672293-33-3 methyl 4-amino-3-iodo-6-methylbenzoate 
• 823-96-1 Trimethylboroxine 

Downstream Products

• 569344-38-3 methyl 2,5-dimethyl-4-propionylaminobenzoate 
• 953393-98-1 methyl 4-{3-[4-(biphenyl-2-ylcarbamoyloxy)piperidin-1-yl]propionylamino}-2,5-dimethylbenzoate 
• 21339-73-1 4-amino-2,5-dimethylbenzoic acid 
• 167626-70-2 2,5-dimethyl-4-propionylamino-benzoic acid 

Relevant academic research and scientific papers

FUNGICIDAL ARYL AMIDINES

This disclosure relates to aryl amidines of Formula I and their use as fungicides. One embodiment of the present disclosure is a use of a compound of Formula I, for protection of a plant against attack by a phytopathogenic organism or the treatment of a plant infested by a phytopathogenic organism, comprising the application of a compound of Formula I, or a composition comprising the compound to soil, a plant, a part of a plant, foliage, and/or roots.

Crystalline forms of a dimethylphenyl compound

The invention relates to crystalline free base forms of biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. This invention also relates to pharmaceutical compositions containing or prepared from such crystalline forms; processes and intermediates useful for preparing such crystalline forms; and methods of using such crystalline forms to, for example, treat a pulmonary disorder.

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

This invention relates to compounds of formula I: wherein R1 and R2 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions and combinations comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compound to, for example, treat pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.